Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease

NCT02226900 is registered in ClinicalTrials.gov with InCor Heart Institute as lead sponsor.

NCT NCT02226900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02226900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease
Lead sponsor
InCor Heart Institute
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2014
Completion date
Not reported
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multivessel coronary artery disease